Accessibility Menu
Lotus Bio-Technology Development logo

Lotus Bio-Technology Development(OTC) LBTD

Market Cap$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Lotus Bio-Technology Development last closing stock price
MetricPriceDate
Last closeUSD 0.002026-02-10
Lotus Bio-Technology Development stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-01-23
1 month+0%USD 0.002025-09-30
3 month+0%USD 0.002025-09-30
Year to date+0%USD 0.002025-09-30
1 year+0%USD 0.002025-01-14
3 year-99.99%USD 0.022023-02-10
5 year-99.99%USD 0.022021-02-11
Since inception-100%USD 0.032014-04-22

Lotus Bio-Technology Development Financials at a Glance

Market Cap

$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$773.98K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-237.57 (Low)

Price

$0.00

Volume

7,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

LBTD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lotus Bio-Technology Development

Lotus Bio-Technology Development Corp. operates as a biotechnology firm focused on processing organic substances and creating natural consumer products for the Chinese market. Established in 2011, the company has evolved significantly since its rebranding in 2016, positioning itself within the agricultural inputs industry.

Products and Services
  • Development of organic and natural consumer products
  • Processing of organic substances for various applications
  • Focus on the Chinese market for product distribution
Growth Outlook
  • Market demand for organic products is increasing in China
  • Potential for expansion into new product lines and markets
  • Strategic positioning in a growing agricultural inputs sector
Financial Highlights
  • Recent quarterly net income reported at -$622
  • Trailing twelve months show a negative P/E ratio of -50
  • Cash and cash equivalents at $50,005 as of last quarter
Lotus Bio-Technology Development Corp. is strategically positioned to capitalize on the growing demand for organic products, particularly in the Chinese market. The company's focus on processing organic substances and developing natural consumer products aligns with global trends favoring sustainability and health-conscious choices. Despite recent financial challenges, including a negative net income and P/E ratio, the company maintains a cash reserve that may support future operations and growth initiatives. The agricultural inputs sector continues to expand, providing potential opportunities for Lotus Bio-Technology to enhance its market presence and product offerings.
AI Generated • Aug 13, 2026

Industry

Entertainment

Headquarters

Port Coquitlam, BC V3C6M1, CA

LBTD Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

31.89%

Return on Capital

N/A

Return on Assets

0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

782.77M

Volume

7.00K

Avg. Volume

0

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$773.98K

EBITDA

-$774.98K

Operating Cash Flow

$263.00

Capital Expenditure

$0.00

Free Cash Flow

$18.02K

Cash & ST Invst.

$50.01K

Total Debt

$16.69K

Lotus Bio-Technology Development Performance Analysis

Lotus Bio-Technology Development sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42017-03-31N/A
Q12017-06-30N/A
Q22017-09-30N/A
Q32017-12-31N/A
Lotus Bio-Technology Development sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42017-03-31-4500.0%
Q12017-06-30100.0%
Q22017-09-30-9097.1%
Q32017-12-3198.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2018YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-$622.00

+96.6%

EBITDA

-$622.00

+96.3%

Quarterly Fundamentals

Name
Q3 2018YOY CHG

Total Cash

$50.01K

N/A

Total Debt

$16.69K

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

0.00%

N/A

Return on Invested Capital

24.18%

N/A

Free Cash Flow

-$1.48K

+86.6%

Operating Cash Flow

-$1.48K

+86.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MLYCFMulti-Metal Development Ltd.
$0.00+0.00%
SILEFSilver Elephant Mining Corp.
$0.11+6.19%
SGTMSustainable Green Team, Ltd.
$0.09-6.64%
GARWFGolden Arrow Resources Corp.
$0.08+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About LBTD

What is the current price of Lotus Bio-Technology Development?

Lotus Bio-Technology Development is trading at $0.00 per share.

What is the 52-week range for Lotus Bio-Technology Development?

Over the past 52 weeks, Lotus Bio-Technology Development has traded between $0.00 and $0.00.

How much debt does Lotus Bio-Technology Development have?

Lotus Bio-Technology Development total debt is unavailable.

How much cash does Lotus Bio-Technology Development have on hand?

Lotus Bio-Technology Development does not have cash on hand data available.

What is Lotus Bio-Technology Development’s dividend yield?

Lotus Bio-Technology Development does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.